Statin use has been demonstrated to reduce C-reactive protein (CRP), a clinical marker of inflammation, in patients with various conditions, including chronic kidney disease, type 2 diabetes, and coronary artery disease [16,17,18]. Here, CRP is linked to type 2 diabetes mellitus.